Surprisingly, tumour cells treated with CDK4/6 inhibitors exhibit a substantial reduction in DNMT1, which lowers DNA methylation activity of endogenous retroviral genes along with immunoregulatory genes. The gene discussed is CDK4; the disease is neoplasm.